IDHC — Integrated Diagnostics Holdings Balance Sheet
0.000.00%
- $312.46m
- $319.11m
- EGP5.72bn
- 98
- 52
- 90
- 96
Annual balance sheet for Integrated Diagnostics Holdings, fiscal year end - December 31st, EGP millions except per share, conversion factor applied.
C2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 877 | 2,350 | 816 | 861 | 1,752 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 364 | 447 | 510 | 685 | 930 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 1,360 | 3,043 | 1,625 | 1,962 | 3,080 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 1,148 | 1,524 | 1,949 | 2,098 | 2,243 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Total Assets | 4,177 | 6,236 | 5,296 | 5,770 | 7,129 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 1,009 | 2,349 | 1,465 | 1,275 | 2,164 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 1,907 | 3,653 | 3,142 | 3,091 | 4,419 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 2,270 | 2,583 | 2,154 | 2,679 | 2,710 |
| Total Liabilities & Shareholders' Equity | 4,177 | 6,236 | 5,296 | 5,770 | 7,129 |
| Total Common Shares Outstanding |